-
Immuneering's (IMRX) "Buy" Rating Reaffirmed at Needham & Company LLC
Source: Buzz FX / 14 Nov 2024 09:01:18 America/New_York
Immuneering's (IMRX) "Buy" Rating Reaffirmed at Needham & Company LLC Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Immuneering ( NASDAQ:IMRX - Get Free Report ) 's stock had its "buy" rating reiterated by equities
Read more...